about
Computational methods in drug discoverySmall-molecule inhibitors of myosin proteinsBCL::Conf: small molecule conformational sampling using a knowledge based rotamer libraryThe future of crystallography in drug discovery.Role of remote sensing, geographical information system (GIS) and bioinformatics in kala-azar epidemiology.Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1Predictive computational models of substrate binding by a nucleoside transporter.Current progress in patient-specific modeling.iDrug: a web-accessible and interactive drug discovery and design platform.ChemT, an open-source software for building template-based chemical libraries.Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitorsArchitecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.Structure-Based Virtual Screening.In silico identification of potential inhibitors targeting Streptococcus mutans sortase A.Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach.Cloud infrastructures for in silico drug discovery: economic and practical aspects.In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA).Computational drug discovery.A survey of yeast genomic assays for drug and target discovery.Lipid simulations: a perspective on lipids in action.Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials.The multi-protein family of sulfotransferases in plants: composition, occurrence, substrate specificity, and functions.Role of computer-aided drug design in modern drug discovery.QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.Advantages of Structure-Based Drug design Approaches in Neurological Disorders.Innovative computer-aided methods for the discovery of new kinase ligands.Computer-aided discovery of new FGFR-1 inhibitors followed by in vitro validation.Estimation of relative free energies of binding using pre-computed ensembles based on the single-step free energy perturbation and the site-identification by Ligand competitive saturation approaches.Rapid activity prediction of HIV-1 integrase inhibitors: harnessing docking energetic components for empirical scoring by chemometric and artificial neural network approaches.Combining docking-based comparative intermolecular contacts analysis and k-nearest neighbor correlation for the discovery of new check point kinase 1 inhibitors.AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways.Ensemble docking to difficult targets in early-stage drug discovery: Methodology and application to fibroblast growth factor 23.Computer aided drug design and its application to the development of potential drugs for neurodegenerative disorders.Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.The use of docking-based comparative intermolecular contacts analysis to identify optimal docking conditions within glucokinase and to discover of new GK activators.Molecular modeling study of a series of amodiaquine analogues with antimalarial activity
P2860
Q26997089-A00729F5-34B8-44BF-AEF1-9B632F295D9CQ27027635-EB7F5524-6482-4DD8-9995-08005842957AQ27902310-EB6CF3E5-9874-44F8-A392-0FC1954E4A28Q28655467-9ECE253B-AE56-43C9-8C0F-9DF2B7D8949DQ30393991-8084B779-3C74-4F2F-B1E2-2F563918CC8AQ30502952-0EFA2D7A-4E9E-46A2-BC4D-CE5395196540Q33553416-6D1ACB68-EB2C-47CD-887C-434B1AAE4229Q33605053-253CF191-A8AD-46EB-BEE1-88B52FC2B4DFQ33712915-A0AEF508-796B-4733-952C-3C67028A26F6Q33993994-2D630C6C-4F04-4BEF-A253-D6F2EAB3AA89Q34530512-C4DBA207-D296-4607-A0CC-3FF523A4A371Q35791501-10510F5C-592A-45A5-ADD3-5E913ADEAD12Q36267055-1B766385-7ED3-4BED-8B9C-72E3DAE9339EQ36327830-130EBAF6-CDD5-47BA-BD27-E7776256D6FAQ36413425-9FC73B2C-0B80-434C-995E-640F7B13D235Q36610117-8CB93DE2-792A-4E74-B907-360C03BA3C4EQ37196859-9F6F9E4D-C225-4FD2-AC17-61BCC379AF85Q37682685-9FED3918-1031-4048-AE94-99EBC9FC150CQ37729463-FCB03270-9999-40DB-8290-1F6A3C89E5C3Q37764979-09EFF5B6-F17D-4D03-BB52-889918FE52ACQ37858333-9373E011-CA56-4401-84BB-ACF2B0E48C1CQ38103912-A2305770-73F1-4706-9F3C-FE32AEBB2FAFQ38264122-2A336EE8-A587-4575-B76F-81F036AE769AQ38553677-FEA02F6F-38EB-4166-90D5-D10A47C8B166Q38743096-534D2500-8AFC-4550-9B89-D57B648206BCQ38775661-AFBA951A-1A21-4712-B11B-B956FFE80CBAQ38814898-F40D63EE-2DB5-407C-93C8-7A76DD8E1B97Q38819860-BC033C27-1A97-4789-8208-9BC810E003D4Q39248995-1C42C497-E38E-4184-AE57-B2E069E4E7C9Q39675574-DC8806CA-6B06-4DF4-B25D-BD9A674593B9Q40959163-B4368D99-D8CD-42B7-B83D-A5F60D727FEAQ46752829-69ECDBF9-50AC-4FE9-B7F3-029AFB768218Q47750111-2B82193B-7BAA-4E67-B861-054A114C3DB2Q47889903-94FA15B5-C440-4AE0-B8A0-6BC6B993258AQ50530099-42E045B8-42A0-42AF-81D6-72ACEB758296Q51103643-F8D94E91-0E0A-4ED3-988A-DB25C9110DEBQ56762944-F64A1544-6AC4-4652-9E93-8F6548060061
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Recent advances in computer-aided drug design.
@ast
Recent advances in computer-aided drug design.
@en
type
label
Recent advances in computer-aided drug design.
@ast
Recent advances in computer-aided drug design.
@en
prefLabel
Recent advances in computer-aided drug design.
@ast
Recent advances in computer-aided drug design.
@en
P2093
P2860
P356
P1476
Recent advances in computer-aided drug design.
@en
P2093
Chun Meng Song
Joo Chuan Tong
Shen Jean Lim
P2860
P304
P356
10.1093/BIB/BBP023
P577
2009-05-11T00:00:00Z